NIDDM
MCID: TYP009
MIFTS: 80

Type 2 Diabetes Mellitus (NIDDM) malady

Endocrine category

Summaries for Type 2 Diabetes Mellitus

Sources:
8Disease Ontology, 64Wikipedia, 47OMIM, 33MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:64 Diabetes mellitus type more...

MalaCards: Type 2 Diabetes Mellitus, also known as diabetes mellitus, non-insulin-dependent, is related to insulin resistance and type 1 diabetes. An important gene associated with Type 2 Diabetes Mellitus is KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11), and among its related pathways are Rho Family GTPases and Insulin Signaling. The drugs insulin and insulin, aspart, human and the compounds glucose and glycogen have been mentioned in the context of this disorder. Affiliated tissues include liver, bone marrow and heart, and related mouse phenotypes are growth/size and homeostasis/metabolism.

Disease Ontology:8 A diabetes mellitus that involves high blood glucose resulting from cells fail to use insulin properly.

Description from OMIM:47 125853

Aliases & Classifications for Type 2 Diabetes Mellitus

Sources:
8Disease Ontology, 10DISEASES, 31LifeMap Discovery™, 45Novoseek, 22GTR, 47OMIM, 61UMLS, 57SNOMED-CT, 40NCIt, 35MeSH, 25ICD10
See all sources

Related Diseases for Type 2 Diabetes Mellitus

Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Type 2 Diabetes Mellitus family:

type 1 diabetes mellitus diabetes mellitus

Diseases related to Type 2 Diabetes Mellitus via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 254)
idRelated DiseaseScoreTop Affiliating Genes
1insulin resistance31.7HNF1B, CAPN10, IDE, PPP1R3A, AKT2, DPP4
2type 1 diabetes31.4PAX4, ENPP1, INSR, LEP
3coronary heart disease31.3IRS1, LEP
4atherosclerosis31.3CAPN10, IRS1, LEP, ENPP1, TCF7L2
5hypoglycemia31.0DPP4, INSR, KCNJ11, SLC2A4
6fatty liver disease31.0LEP
7glucose intolerance30.9IDE, CAPN10, DPP4, ENPP1, PAX4, SLC2A4
8hypertriglyceridemia30.8INSR, SLC2A4, LEP, IRS1
9insulinoma30.8PAX4, KCNJ11, INSR, GPD2
10polycystic ovary syndrome30.7LEP, INSR, IRS1, CAPN10
11morbid obesity30.7LEP
12maturity-onset diabetes of the young30.5KCNJ11, HNF1B, PAX4
13hyperandrogenism30.5LEP, INSR, CAPN10
14gestational diabetes30.4CAPN10, ENPP1, TCF7L2, SLC2A4, LEP, INSR
15hyperinsulinism30.4LEP, KCNJ11, IRS1, INSR
16acanthosis nigricans30.4LEP, INSR
17stomach cancer30.2SLC2A4, TCF7L2, TCF4, PPP1R3A
18neonatal diabetes mellitus30.2KCNJ11, HNF1B
19adenoma30.2INSR, TCF7L2
20uremia30.2INSR, LEP, ENPP1
21cystic fibrosis30.2CAPN10, KCNJ11
22hepatitis c30.2IRS1
23type 1 diabetes mellitus11.0
24coronary artery disease,10.9
25diabetic nephropathy10.9
26diabetes, type 210.9
27insulin-resistance type b10.8
28autonomic neuropathy10.8
29vascular disease10.7
30lip disease10.7
31diabetes mellitus, insulin-dependent-110.7
32n syndrome10.6
33hypercholesterolemia10.6
34peripheral vascular disease10.5
35alzheimer's disease10.5
36tuberculosis10.5
37cardiovascular disease risk factor10.5
38autonomic dysfunction10.5
39diabetes mellitus, insulin-dependent, 1910.5
40bacteriuria10.5
41cushing's syndrome10.5
42hemochromatosis10.5
43sleep disorder10.5
44homocysteine plasma level10.5
45bone fracture10.4
46proliferative diabetic retinopathy10.4
47acute pancreatitis10.4
48pulmonary tuberculosis10.4
49diabetic ketoacidosis10.4
50hyperuricemia10.4

Graphical network of the top 20 diseases related to Type 2 Diabetes Mellitus:



Diseases related to type 2 diabetes mellitus

Clinical Features for Type 2 Diabetes Mellitus

Sources:
47OMIM
See all sources

Clinical features from OMIM:

125853

Drugs & Therapeutics for Type 2 Diabetes Mellitus

Sources:
5CenterWatch, 42NIH Clinical Center, 6ClinicalTrials, 31LifeMap Discovery™, 61UMLS, 41NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Type 2 Diabetes Mellitus

Drug clinical trials:

Search ClinicalTrials for Type 2 Diabetes Mellitus

Search NIH Clinical Center for Type 2 Diabetes Mellitus

Highlights from CenterWatch's Drugs in Clinical Trials Database for Type 2 Diabetes Mellitus:

idCompanyCompoundMechanismPhase
1PhaseBio PharmaceuticalsGlymeraA long acting GLP-1 analogIIb
2RochealeglitazarA PPAR alpha and gamma modulatorII and III
3Boehringer Ingelheim/Eli LillyempagliflozinA SGLT-2 inhibitorIII
4Gilead SciencesranolazineA pFOX inhibitorIII
5Zealand PharmalixisenatideA glucagon-like peptide 1 receptor agonistIII

Inferred drug relations via UMLS61/NDF-RT41:

Show with subtypes

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Read about Type 2 Diabetes Mellitus cell therapies at LifeMap Discovery.

Genetic Tests for Type 2 Diabetes Mellitus

Sources:
22GTR
See all sources

Genetic tests related to Type 2 Diabetes Mellitus:

id Genetic test Affiliating Genes
1 Diabetes Mellitus Type 222

Anatomical Context for Type 2 Diabetes Mellitus

Sources:
31LifeMap Discovery™, 33MalaCards
See all sources

MalaCards organs/tissues related to Type 2 Diabetes Mellitus:

33
Liver, Bone marrow, Heart, Pancreas, Thyroid, Monocytes, T cells, B cells, Endothelial

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Type 2 Diabetes Mellitus:
id TissueAnatomical CompartmentCell Relevance
1 PancreasIslets of LangerhansMature Beta Cells Potential therapeutic candidate, affected by disease
2 AdiposeSubcutaneous White AdiposeMesenchymal Stem Cells Potential therapeutic candidate
3 AdiposeSubcutaneous White AdiposeStromal Cells Potential therapeutic candidate

Animal Models for Type 2 Diabetes Mellitus or affiliated genes

Sources:
37MGI, 28inGenious Targeting Laboratory
See all sources

Publications for Type 2 Diabetes Mellitus

Sources:
51PubMed
See all sources

Articles related to Type 2 Diabetes Mellitus:

(show all 46)
idTitleAuthorsYear
1
Re: "Prevalence of Diagnosed and Undiagnosed Type 2 Diabetes Mellitus Among US Adolescents: Results From the Continuous NHANES, 1999-2010". (24243744)
2014
2
Monocyte chemoattractant protein-1 -2518G/A gene polymorphism and the risk of nephropathy in type 2 diabetes mellitus among Asians: a meta-analysis. (24059294)
2014
3
Type 2 diabetes mellitus in 2013: A central role of the gut in glucose homeostasis. (24322651)
2014
4
Re: "Prevalence of Diagnosed and Undiagnosed Type 2 Diabetes Mellitus Among US Adolescents: Results From the Continuous NHANES, 1999-2010". (24243743)
2014
5
Glycaemic control and implementation of the ADA/EASD-2006 consensus algorithm in type 2 diabetes mellitus patients in primary care in Spain. (24341300)
2014
6
Letter: diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus (diabetes metab j 2013;37:262-9). (24199169)
2013
7
Bayesian analysis of the geographical variation of type 1 diabetes mellitus in under 15 yr olds in northeast Spain, 1991-2009. (22816867)
2013
8
Ambulatory Treatment of Type 2 Diabetes Mellitus in the United States, 1997-2012. (24198301)
2013
9
Trends in the incidence of childhood type 1 diabetes mellitus in Beijing based on hospitalization data from 1995 to 2010. (24216776)
2013
10
Association of the G-250A promoter polymorphism in the hepatic lipase gene with the risk of type 2 diabetes mellitus. (23351562)
2013
11
Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999-2010. (23887044)
2013
12
Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. (23954219)
2013
13
Response: diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus (diabetes metab j 2013;37:262-9). (24199170)
2013
14
Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002-2012 literature review. (24219205)
2013
15
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008. (22075092)
2012
16
Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995-2006). (22057636)
2012
17
Incidence and modes of presentation of childhood type 1 diabetes mellitus in Malta between 2006 and 2010. (22151907)
2012
18
Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy. (22183128)
2012
19
Epidemiology of type 1 diabetes mellitus in Cyprus: rising incidence at the dawn of the 21st century. (22450348)
2012
20
The 223A>G polymorphism of the leptin receptor gene is associated with macroangiopathy in type 2 diabetes mellitus. (21938427)
2012
21
Alcohol consumption and the risk of type 2 diabetes mellitus: effect modification by hypercholesterolemia: the Third Korea National Health and Nutrition Examination Survey (2005). (23017317)
2012
22
Letter: a retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients (korean diabetes j 2010;34:359-67). (21537418)
2011
23
Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus. (21916971)
2011
24
Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. (21638131)
2011
25
Response: a retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients (korean diabetes j 2010;34:359-67). (21537419)
2011
26
Tumor necrosis factor-alpha gene promoter -308G/A and -238G/A polymorphisms in Mexican patients with type 2 diabetes mellitus. (21508505)
2011
27
Comment on "Lw fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus (pancreas. 2008;36:274-278)". (19390407)
2009
28
Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease]. (19350521)
2009
29
An analysis of the prevalence of thyroid autoantibodies: thyroid peroxidase antibodies (ATA) and thyroglobulin antibodies (ATG) in children with newly diagnosed diabetes mellitus type 1 during 2000-2004 in the Upper Silesia region, Poland. (17932620)
2008
30
National trends in treatment of type 2 diabetes mellitus, 1994-2007. (18955637)
2008
31
Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. (18593823)
2008
32
Association of the chromosomal region 2q35 with type 1 diabetes mellitus in the Russian patients from Moscow]. (18619042)
2008
33
Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus. (17445540)
2007
34
Association of the promoter polymorphism -232C/G of the phosphoenolpyruvate carboxykinase gene (PCK1) with Type 2 diabetes mellitus. (16620271)
2006
35
Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-alpha gene and -308G/A of tumor necrosis factor alpha gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. (16979413)
2006
36
Comment on: Biason-Lauber A, Boehm B, Lang-Muritano M, et al (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900-905. (16362282)
2006
37
Comment to: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900-905. (16132953)
2005
38
To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900-905. (16132962)
2005
39
To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900-905. (16132946)
2005
40
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism. (16050950)
2005
41
The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls. (16285997)
2005
42
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. (15349727)
2004
43
The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish diabetes prevention study. (15126514)
2004
44
-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. (12819903)
2003
45
A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13. (12727978)
2003
46
Assignment of Ptprn2, the gene encoding receptor-type protein tyrosine phosphatase IA-2beta, a major autoantigen in insulin-dependent diabetes mellitus, to mouse chromosome region 12F. (9858807)
1998

Genetic Variations for Type 2 Diabetes Mellitus

Expression for genes affiliated with Type 2 Diabetes Mellitus

Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Type 2 Diabetes Mellitus

Search GEO for disease gene expression data for Type 2 Diabetes Mellitus.

Pathways for genes affiliated with Type 2 Diabetes Mellitus

Sources:
52QIAGEN, 38NCBI BioSystems Database, 12EMD Millipore, 54Reactome, 30KEGG, 4Cell Signaling Technology, 53R&D Systems, 50PharmGKB, 60Tocris Bioscience
See all sources

Pathways related to Type 2 Diabetes Mellitus according to GeneCards/GeneDecks:

(show all 24)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
11.4CAPN10, IRS1, PPP1R3A, AKT2, INSR, TCF4
211.3IRS1, PPP1R3A, AKT2, INSR, SLC2A4, ENPP1
3
Hide members
11.1TCF7L2, TCF4, INSR, AKT2, IRS1
4
Development Leptin signaling via PI3K-dependent pathway
Hide members
11.1SLC2A4, LEP, AKT2, IRS1, KCNJ11
5
Hide members
11.1IDE, IRS1, AKT2, INSR, LEP
611.1PPARGC1B, AKT2, INSR, LEP, SLC2A4
711.1IRS1, AKT2, INSR, SLC2A4, ENPP1
8
Hide members
11.1SLC2A4, LEP, INSR, AKT2, IRS1
911.1IRS1, AKT2, INSR, LEP, SLC2A4
10
Hide members
11.1KCNJ11, HNF1B, IRS1, INSR, SLC2A4
11
Translation Insulin regulation of translation
Hide members
11.1IRS1, PPP1R3A, AKT2, INSR, SLC2A4
12
Hide members
11.0TCF7L2, INSR, AKT2, IRS1
1311.0SLC2A4, LEP, AKT2, IRS1
1411.0SLC2A4, INSR, AKT2, PPP1R3A
15
Hide members
11.0IRS1, AKT2, INSR, SLC2A4
16
Hide members
11.0IRS1, PPP1R3A, INSR, SLC2A4
17
Hide members
10.9TCF7L2, AKT2, IRS1
18
Hide members
10.9HNF1B, AKT2, PAX4
19
Hide members
10.9SLC2A4, TCF4, PAX4
20
Hide members
10.9INSR, AKT2, PPP1R3A
21
Hide members
10.9IRS1, AKT2, INSR
2210.9IRS1, AKT2, INSR
2310.9LEP, INSR, IRS1
24
Hide members
10.7INSR, IRS1

Compounds for genes affiliated with Type 2 Diabetes Mellitus

Sources:
45Novoseek, 24HMDB, 50PharmGKB, 11DrugBank, 60Tocris Bioscience, 29IUPHAR
See all sources

Compounds related to Type 2 Diabetes Mellitus according to GeneCards/GeneDecks:

(show top 50)    (show all 59)
idCompoundScoreTop Affiliating Genes
1glucose4512.4IRS1, KCNJ11, HNF1B, IDE, PPP1R3A, INSR
2glycogen45 2413.2CAPN10, IRS1, PPP1R3A, AKT2, ENPP1, TCF7L2
3lipid4512.2LEP, IRS1, IDE, CAPN10, PPP1R3A, AKT2
4phosphatidylinositol4511.9IDE, IRS1, INSR, LEP, SLC2A4, TCF7L2
5serine4511.9ENPP1, LEP, INSR, DPP4, AKT2, IRS1
6metformin45 50 1113.8INSR, SLC2A4, LEP, DPP4, IRS1, KCNJ11
7arginine4511.8LEP, IRS1, KCNJ11, CAPN10, HNF1B, IDE
8glycerol45 11 2413.7IRS1, IDE, DPP4, SLC2A4, LEP, INSR
9rapamycin4511.7SLC2A4, LEP, IRS1, AKT2, INSR, ENPP1
10ly2940024511.7IRS1, TCF7L2, SLC2A4, LEP, INSR, AKT2
11testosterone45 60 11 2414.6TCF7L2, SLC2A4, LEP, IRS1, IDE, INSR
12c-peptide4511.6INSR, LEP, DPP4, KCNJ11, IRS1
13rosiglitazone45 50 29 11 2415.6IRS1, DPP4, INSR, LEP, SLC2A4
14glutamate4511.5DPP4, IDE, IRS1, LEP, INSR, KCNJ11
15valine4511.5INSR, IDE, SLC2A4, DPP4, KCNJ11
16wortmannin4511.5LEP, SLC2A4, IRS1, AKT2, INSR
17fatty acid4511.5PPARGC1B, SLC2A4, ENPP1, IRS1, LEP
18sulfonylurea4511.4KCNJ11, DPP4, IRS1, SLC2A4
19thiazolidinedione4511.4DPP4, SLC2A4, LEP, IRS1
20streptozotocin4511.4INSR, IRS1, DPP4, SLC2A4
21glibenclamide45 29 50 6014.4LEP, INSR, KCNJ11, SLC2A4
222-deoxyglucose45 1112.4IRS1, SLC2A4, INSR, PPP1R3A
23pioglitazone45 50 29 1114.4IRS1, INSR, LEP, SLC2A4
24troglitazone45 29 60 1114.4IRS1, SLC2A4, LEP, INSR
25vanadium4511.3INSR, IRS1, SLC2A4
26repaglinide45 50 1113.3PAX4, KCNJ11, TCF7L2
27glimepiride45 50 1113.3INSR, KCNJ11, SLC2A4
28gliclazide45 50 1113.3KCNJ11, INSR, SLC2A4
29aicar45 11 2413.2SLC2A4, LEP, INSR
30phenylarsine oxide4511.2IRS1, INSR, SLC2A4
31sb 20358045 6012.2IRS1, AKT2, INSR, SLC2A4
32glycerol 3-phosphate45 2412.2GPD2, LEP, SLC2A4
33h2o24511.2SLC2A4, LEP, INSR, GPD2, IRS1
34glucosamine45 11 2413.2IRS1, INSR, SLC2A4
35tamoxifen45 50 29 1114.1IRS1, LEP, SLC2A4, AKT2
36[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID1111.1IRS1, INSR
37sulfonamides, urea derivatives5011.1TCF7L2, KCNJ11
38losartan45 50 29 1114.1SLC2A4, IRS1, LEP
39exenatide45 1112.0LEP, DPP4
40anisomycin45 1112.0SLC2A4, IRS1, INSR
413-o-methylglucose4511.0INSR, SLC2A4
42vanadyl sulfate4511.0IRS1, INSR
43grp-14511.0SLC2A4, INSR
44ag 10244511.0IRS1, INSR
45n-ethylmaleimide45 1111.9SLC2A4, INSR, IDE
46cycloheximide4510.9DPP4
47moxonidine4510.8INSR, IRS1
48pramlintide45 1111.7DPP4, LEP
49Insulin Regular 1110.6IDE, INSR
50rimonabant45 29 1112.4LEP, DPP4

GO Terms for genes affiliated with Type 2 Diabetes Mellitus

Sources:
16Gene Ontology
See all sources

Cellular components related to Type 2 Diabetes Mellitus according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1insulin receptor complexGO:00589910.7INSR, IRS1

Biological processes related to Type 2 Diabetes Mellitus according to GeneCards/GeneDecks:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1cellular response to insulin stimulusGO:03286911.5SLC2A4, INSR, AKT2, IRS1, CAPN10, ENPP1
2positive regulation of glucose importGO:04632611.2INSR, CAPN10, IRS1, AKT2
3glucose homeostasisGO:04259311.2SLC2A4, IRS1, INSR, TCF7L2
4insulin receptor signaling pathwayGO:00828611.1AKT2, IRS1, IDE, INSR
5positive regulation of glycogen biosynthetic processGO:04572511.1INSR, AKT2, IRS1
6positive regulation of developmental growthGO:04863910.9INSR, LEP
7positive regulation of glucose import in response to insulin stimulusGO:200127510.8AKT2, IRS1
8positive regulation of glucose metabolic processGO:01090710.8IRS1, AKT2
9positive regulation of insulin receptor signaling pathwayGO:04662810.7LEP, IRS1
10embryonic digestive tract morphogenesisGO:04855710.7HNF1B, TCF7L2
11positive regulation of fatty acid beta-oxidationGO:03200010.6IRS1, AKT2
12glucose metabolic processGO:00600610.6AKT2, KCNJ11, LEP

Molecular functions related to Type 2 Diabetes Mellitus according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1insulin-like growth factor receptor bindingGO:00515910.7INSR, IRS1
2insulin bindingGO:04355910.4INSR, IDE

Products for genes affiliated with Type 2 Diabetes Mellitus

  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Type 2 Diabetes Mellitus

3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet